By Marisa Wong
Milwaukee, April 1 - Active Biotech AB raised SEK 149 million through a directed share issue placed with funds managed by Sectoral Asset Management Inc., according to a news release.
Active Biotech sold 1,418,000 new shares at SEK 105 per share
Funds from the placement will be used to strengthen the company's capital base and enable the continued development and growth of its project portfolio.
Active Biotech is a Lund, Sweden, biotechnology company focusing on autoimmune and inflammatory diseases and cancer.
| Issuer: | Active Biotech AB
|
| Issue: | Shares
|
| Amount: | SEK 149 million
|
| Shares: | 1,418,000
|
| Price: | SEK 105
|
| Warrants: | No
|
| Investor: | Sectoral Asset Management Inc.
|
| Distribution: | Direct offering
|
| Announcement date: | April 1
|
| Stock symbol: | Stockholm: ACTI
|
| Stock price: | SEK 113.50 at close April 1, 2010
|
| Market capitalization: | SEK 7.28 billion
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
